Nissay Asset Management Corp Japan ADV Increases Position in Cognex Co. (NASDAQ:CGNX)

Nissay Asset Management Corp Japan ADV grew its stake in Cognex Co. (NASDAQ:CGNX) by 10.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,747 shares of the scientific and technical instruments company’s stock after acquiring an additional 1,543 shares during the quarter. Nissay Asset Management Corp Japan ADV’s holdings in Cognex were worth $1,000,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in CGNX. Sumitomo Mitsui Trust Holdings Inc. grew its stake in Cognex by 286.5% during the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,570,605 shares of the scientific and technical instruments company’s stock worth $108,531,000 after buying an additional 1,905,545 shares during the last quarter. Norges Bank purchased a new position in Cognex during the 4th quarter worth $103,498,000. Pictet Asset Management Ltd. grew its stake in Cognex by 70.9% during the 1st quarter. Pictet Asset Management Ltd. now owns 1,633,481 shares of the scientific and technical instruments company’s stock worth $68,966,000 after buying an additional 677,734 shares during the last quarter. Fundsmith LLP grew its stake in Cognex by 29.2% during the 1st quarter. Fundsmith LLP now owns 1,508,999 shares of the scientific and technical instruments company’s stock worth $63,710,000 after buying an additional 341,182 shares during the last quarter. Finally, New York State Common Retirement Fund grew its stake in Cognex by 16.3% during the 1st quarter. New York State Common Retirement Fund now owns 2,086,580 shares of the scientific and technical instruments company’s stock worth $88,095,000 after buying an additional 292,901 shares during the last quarter. Institutional investors and hedge funds own 93.97% of the company’s stock.

NASDAQ CGNX opened at $66.87 on Friday. The stock has a market capitalization of $11.57 billion, a price-to-earnings ratio of 82.56 and a beta of 1.79. Cognex Co. has a twelve month low of $35.20 and a twelve month high of $66.95. The company has a current ratio of 4.47, a quick ratio of 3.59 and a debt-to-equity ratio of 0.02. The stock has a 50-day moving average of $60.53 and a 200 day moving average of $53.68.

Cognex (NASDAQ:CGNX) last released its quarterly earnings results on Wednesday, July 29th. The scientific and technical instruments company reported ($0.01) earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.11). The business had revenue of $169.10 million during the quarter, compared to analyst estimates of $149.90 million. Cognex had a return on equity of 10.67% and a net margin of 20.50%. The business’s revenue for the quarter was down 15.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.27 EPS. Equities analysts predict that Cognex Co. will post 0.58 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Friday, August 14th will be paid a dividend of $0.055 per share. The ex-dividend date is Thursday, August 13th. This represents a $0.22 annualized dividend and a yield of 0.33%. Cognex’s dividend payout ratio (DPR) is currently 18.97%.

CGNX has been the topic of several research analyst reports. Raymond James boosted their target price on Cognex from $48.00 to $60.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 28th. Robert W. Baird cut Cognex from a “neutral” rating to an “underperform” rating and lifted their price target for the stock from $44.00 to $45.00 in a research report on Tuesday, June 2nd. BidaskClub raised Cognex from a “buy” rating to a “strong-buy” rating in a research report on Wednesday. UBS Group lifted their price target on Cognex from $43.00 to $56.00 and gave the stock a “neutral” rating in a research report on Friday, May 8th. Finally, Zacks Investment Research cut Cognex from a “hold” rating to a “sell” rating in a research report on Wednesday, July 1st. Five research analysts have rated the stock with a sell rating, six have given a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $53.40.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. It provides machine vision products, which are used to automate the manufacture and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

See Also: What is FinTech?

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.